Skip to main content

Peer Review reports

From: Clinical efficacy and safety of full-dose versus half-dose corticosteroids plus leflunomide for IgA nephropathy

Original Submission
1 Mar 2021 Submitted Original manuscript
6 May 2021 Reviewed Reviewer Report - Cristiana Rollino
10 May 2021 Reviewed Reviewer Report
29 May 2021 Author responded Author comments - Gaosi Xu
Resubmission - Version 2
29 May 2021 Submitted Manuscript version 2
1 Jun 2021 Author responded Author comments - Gaosi Xu
Resubmission - Version 3
1 Jun 2021 Submitted Manuscript version 3
3 Jun 2021 Author responded Author comments - Gaosi Xu
Resubmission - Version 4
3 Jun 2021 Submitted Manuscript version 4
14 Jun 2021 Reviewed Reviewer Report
Resubmission - Version 5
Submitted Manuscript version 5
Publishing
19 Jun 2021 Editorially accepted
4 Nov 2021 Article published 10.1186/s12882-021-02555-z

You can find further information about peer review here.

Back to article page